{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:43:07Z","timestamp":1762868587792,"version":"3.37.3"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T00:00:00Z","timestamp":1626739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T00:00:00Z","timestamp":1626739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["CAN 2017\/768"],"award-info":[{"award-number":["CAN 2017\/768"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2015\u20134870"],"award-info":[{"award-number":["2015\u20134870"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007051","name":"Uppsala University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Adrenocortical carcinoma is a rare aggressive disease commonly recurring regardless of radical surgery. Although data on genomic alterations in malignant tumors are accumulating, knowledge of molecular events of importance for initiation of adrenocortical transformation is scarce. In an attempt to recognize early molecular alterations, we used adrenals from young multiple endocrine neoplasia type 1 conventional knock-out mice (<jats:italic>Men1<\/jats:italic><jats:sup>+\/\u2212<\/jats:sup>) closely mimicking the human MEN1 trait (i.e. transformation of pituitary, parathyroid, endocrine pancreatic, and adrenocortical cells). MicroRNA array and hierarchical clustering showed a distinct pattern. Twenty miRNAs were significantly upregulated and eleven were downregulated in<jats:italic>Men1<\/jats:italic><jats:sup>+\/\u2212<\/jats:sup>compared to wild type littermates. The latter included the known suppressor miRNA miR-486-3p, which was chosen for transfection in human adrenocortical carcinoma cell lines H295R and SW13. Cell growth decreased in miR-486-3p overexpressing clones and levels of the predicted target gene fatty acid synthase (FASN) and its downstream product, palmitic acid, were lowered. In conclusion, heterozygous inactivation of<jats:italic>Men1<\/jats:italic>in adrenals results in distinct miRNA profile regulating expression of genes with impact on tumorigenesis, e.g. transcription, nucleic acid and lipid metabolism. Low levels of miR-486-3p in the early stages of transformation may contribute to proliferation by increasing FASN and thus fatty acid production. FASN as a potentially druggable target for treatment of the devastating disease adrenocortical carcinoma warrants further studies.<\/jats:p>","DOI":"10.1038\/s41598-021-94154-z","type":"journal-article","created":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T10:26:57Z","timestamp":1626776817000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["MiR-486-3p was downregulated at microRNA profiling of adrenals of multiple endocrine neoplasia type 1 mice, and inhibited human adrenocortical carcinoma cell lines"],"prefix":"10.1038","volume":"11","author":[{"given":"Su-Chen","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azita","family":"Monazzam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoud","family":"Razmara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"St\u00e5lberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Britt","family":"Skogseid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,20]]},"reference":[{"key":"94154_CR1","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/0002-9343(54)90353-8","volume":"16","author":"P Wermer","year":"1954","unstructured":"Wermer, P. Genetic aspects of adenomatosis of endocrine glands. Am. J. Med. 16, 363\u2013371. https:\/\/doi.org\/10.1016\/0002-9343(54)90353-8 (1954).","journal-title":"Am. J. Med."},{"key":"94154_CR2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1210\/jcem.75.1.1352309","volume":"75","author":"B Skogseid","year":"1992","unstructured":"Skogseid, B. et al. Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. J. Clin. Endocrinol. Metab. 75, 76\u201381. https:\/\/doi.org\/10.1210\/jcem.75.1.1352309 (1992).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"94154_CR3","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00423-006-0124-7","volume":"392","author":"J Waldmann","year":"2007","unstructured":"Waldmann, J. et al. Adrenal involvement in multiple endocrine neoplasia type 1: results of 7 years prospective screening. Langenbecks Arch Surg 392, 437\u2013443. https:\/\/doi.org\/10.1007\/s00423-006-0124-7 (2007).","journal-title":"Langenbecks Arch Surg"},{"key":"94154_CR4","doi-asserted-by":"publisher","first-page":"6075","DOI":"10.1128\/mcb.23.17.6075-6085.2003","volume":"23","author":"JS Crabtree","year":"2003","unstructured":"Crabtree, J. S. et al. Of mice and MEN1: Insulinomas in a conditional mouse knockout. Mol. Cell. Biol. 23, 6075\u20136085. https:\/\/doi.org\/10.1128\/mcb.23.17.6075-6085.2003 (2003).","journal-title":"Mol. Cell. Biol."},{"key":"94154_CR5","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/ijc.22288","volume":"120","author":"KA Loffler","year":"2007","unstructured":"Loffler, K. A. et al. Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1. Int. J. Cancer 120, 259\u2013267. https:\/\/doi.org\/10.1002\/ijc.22288 (2007).","journal-title":"Int. J. Cancer"},{"key":"94154_CR6","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1126\/science.276.5311.404","volume":"276","author":"SC Chandrasekharappa","year":"1997","unstructured":"Chandrasekharappa, S. C. et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276, 404\u2013407. https:\/\/doi.org\/10.1126\/science.276.5311.404 (1997).","journal-title":"Science"},{"key":"94154_CR7","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1101\/gad.949001","volume":"15","author":"KC Quon","year":"2001","unstructured":"Quon, K. C. & Berns, A. Haplo-insufficiency? Let me count the ways. Genes Dev. 15, 2917\u20132921. https:\/\/doi.org\/10.1101\/gad.949001 (2001).","journal-title":"Genes Dev."},{"key":"94154_CR8","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1210\/jcem.84.1.5388","volume":"84","author":"C Heppner","year":"1999","unstructured":"Heppner, C. et al. MEN1 gene analysis in sporadic adrenocortical neoplasms. J. Clin. Endocrinol. Metab. 84, 216\u2013219. https:\/\/doi.org\/10.1210\/jcem.84.1.5388 (1999).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"94154_CR9","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/ng.2953","volume":"46","author":"G Assie","year":"2014","unstructured":"Assie, G. et al. Integrated genomic characterization of adrenocortical carcinoma. Nat. Genet 46, 607\u2013612. https:\/\/doi.org\/10.1038\/ng.2953 (2014).","journal-title":"Nat. Genet"},{"key":"94154_CR10","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.ccell.2016.04.002","volume":"29","author":"S Zheng","year":"2016","unstructured":"Zheng, S. et al. Comprehensive pan-genomic characterization of adrenocortical carcinoma. Cancer Cell 29, 723\u2013736. https:\/\/doi.org\/10.1016\/j.ccell.2016.04.002 (2016).","journal-title":"Cancer Cell"},{"key":"94154_CR11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1530\/JME-18-0262","volume":"62","author":"NG Nicolson","year":"2019","unstructured":"Nicolson, N. G., Korah, R. & Carling, T. Adrenocortical cancer cell line mutational profile reveals aggressive genetic background. J. Mol. Endocrinol. 62, 179\u2013186. https:\/\/doi.org\/10.1530\/JME-18-0262 (2019).","journal-title":"J. Mol. Endocrinol."},{"key":"94154_CR12","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1136\/gut.2006.108910","volume":"56","author":"M Anlauf","year":"2007","unstructured":"Anlauf, M. et al. Allelic deletion of the MEN1 gene in duodenal gastrin and somatostatin cell neoplasms and their precursor lesions. Gut 56, 637\u2013644. https:\/\/doi.org\/10.1136\/gut.2006.108910 (2007).","journal-title":"Gut"},{"key":"94154_CR13","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1210\/en.2011-1924","volume":"153","author":"MH Lejonklou","year":"2012","unstructured":"Lejonklou, M. H., Barbu, A., Stalberg, P. & Skogseid, B. Accelerated proliferation and differential global gene expression in pancreatic islets of five-week-old heterozygous Men1 mice: Men1 is a haploinsufficient suppressor. Endocrinology 153, 2588\u20132598. https:\/\/doi.org\/10.1210\/en.2011-1924 (2012).","journal-title":"Endocrinology"},{"key":"94154_CR14","doi-asserted-by":"publisher","first-page":"E493","DOI":"10.1210\/jc.2014-3282","volume":"100","author":"CC Juhlin","year":"2015","unstructured":"Juhlin, C. C. et al. Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma. J. Clin. Endocrinol. Metab. 100, E493-502. https:\/\/doi.org\/10.1210\/jc.2014-3282 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"94154_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087951","volume":"9","author":"H Kjellin","year":"2014","unstructured":"Kjellin, H. et al. Differentially expressed proteins in malignant and benign adrenocortical tumors. PLoS ONE 9, e87951. https:\/\/doi.org\/10.1371\/journal.pone.0087951 (2014).","journal-title":"PLoS ONE"},{"key":"94154_CR16","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1530\/ERC-11-0082","volume":"18","author":"DM Ozata","year":"2011","unstructured":"Ozata, D. M. et al. The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma. Endocr. Relat. Cancer 18, 643\u2013655. https:\/\/doi.org\/10.1530\/ERC-11-0082 (2011).","journal-title":"Endocr. Relat. Cancer"},{"key":"94154_CR17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215\u2013233. https:\/\/doi.org\/10.1016\/j.cell.2009.01.002 (2009).","journal-title":"Cell"},{"key":"94154_CR18","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrg2843","volume":"11","author":"J Krol","year":"2010","unstructured":"Krol, J., Loedige, I. & Filipowicz, W. The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 11, 597\u2013610. https:\/\/doi.org\/10.1038\/nrg2843 (2010).","journal-title":"Nat. Rev. Genet."},{"key":"94154_CR19","doi-asserted-by":"publisher","first-page":"4677","DOI":"10.1200\/JCO.2005.05.5194","volume":"24","author":"C Roldo","year":"2006","unstructured":"Roldo, C. et al. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J. Clin. Oncol. 24, 4677\u20134684. https:\/\/doi.org\/10.1200\/JCO.2005.05.5194 (2006).","journal-title":"J. Clin. Oncol."},{"key":"94154_CR20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nature06487","volume":"451","author":"SF Tavazoie","year":"2008","unstructured":"Tavazoie, S. F. et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451, 147\u2013152. https:\/\/doi.org\/10.1038\/nature06487 (2008).","journal-title":"Nature"},{"key":"94154_CR21","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/ng865","volume":"30","author":"EC Lai","year":"2002","unstructured":"Lai, E. C. Micro RNAs are complementary to 3\u2019 UTR sequence motifs that mediate negative post-transcriptional regulation. Nat. Genet. 30, 363\u2013364. https:\/\/doi.org\/10.1038\/ng865 (2002).","journal-title":"Nat. Genet."},{"key":"94154_CR22","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/s0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281\u2013297. https:\/\/doi.org\/10.1016\/s0092-8674(04)00045-5 (2004).","journal-title":"Cell"},{"key":"94154_CR23","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nrg1379","volume":"5","author":"L He","year":"2004","unstructured":"He, L. & Hannon, G. J. MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 5, 522\u2013531. https:\/\/doi.org\/10.1038\/nrg1379 (2004).","journal-title":"Nat. Rev. Genet."},{"key":"94154_CR24","unstructured":"Chu, X. Aspects of MEN1 Tumorigenesis in Endocrine Pancreas and Adrenal Glands, Acta Universitatis Upsaliensis, ISBN:\u00a0978-91-554-9273-1 (2015)."},{"key":"94154_CR25","doi-asserted-by":"publisher","unstructured":"Berindan-Neagoe, I., Monroig Pdel, C., Pasculli, B. & Calin, G. A. MicroRNAome genome: a treasure for cancer diagnosis and therapy. CA Cancer J. Clin. 64, 311\u2013336, doi:https:\/\/doi.org\/10.3322\/caac.21244 (2014).","DOI":"10.3322\/caac.21244"},{"key":"94154_CR26","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.bbrc.2011.02.065","volume":"406","author":"JK Park","year":"2011","unstructured":"Park, J. K. et al. miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor. Biochem. Biophys. Res. Commun. 406, 518\u2013523. https:\/\/doi.org\/10.1016\/j.bbrc.2011.02.065 (2011).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"94154_CR27","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/hep.26662","volume":"59","author":"L Lim","year":"2014","unstructured":"Lim, L. et al. MicroRNA-494 within an oncogenic microRNA megacluster regulates G1\/S transition in liver tumorigenesis through suppression of mutated in colorectal cancer. Hepatology 59, 202\u2013215. https:\/\/doi.org\/10.1002\/hep.26662 (2014).","journal-title":"Hepatology"},{"key":"94154_CR28","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1038\/onc.2009.192","volume":"28","author":"KH Lee","year":"2009","unstructured":"Lee, K. H. et al. MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation. Oncogene 28, 3360\u20133370. https:\/\/doi.org\/10.1038\/onc.2009.192 (2009).","journal-title":"Oncogene"},{"key":"94154_CR29","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1677\/ERC-09-0096","volume":"16","author":"Z Tombol","year":"2009","unstructured":"Tombol, Z. et al. Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis. Endocr. Relat. Cancer 16, 895\u2013906. https:\/\/doi.org\/10.1677\/ERC-09-0096 (2009).","journal-title":"Endocr. Relat. Cancer"},{"key":"94154_CR30","doi-asserted-by":"publisher","first-page":"4666","DOI":"10.1158\/0008-5472.CAN-09-3970","volume":"70","author":"M Doghman","year":"2010","unstructured":"Doghman, M. et al. Regulation of insulin-like growth factor-mammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors. Cancer Res. 70, 4666\u20134675. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-3970 (2010).","journal-title":"Cancer Res."},{"key":"94154_CR31","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1002\/cncr.25724","volume":"117","author":"EE Patterson","year":"2011","unstructured":"Patterson, E. E., Holloway, A. K., Weng, J., Fojo, T. & Kebebew, E. MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy. Cancer 117, 1630\u20131639. https:\/\/doi.org\/10.1002\/cncr.25724 (2011).","journal-title":"Cancer"},{"key":"94154_CR32","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.bbrc.2013.01.016","volume":"431","author":"Y Li","year":"2013","unstructured":"Li, Y., Zhu, X., Xu, W., Wang, D. & Yan, J. miR-330 regulates the proliferation of colorectal cancer cells by targeting Cdc42. Biochem. Biophys. Res. Commun. 431, 560\u2013565. https:\/\/doi.org\/10.1016\/j.bbrc.2013.01.016 (2013).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"94154_CR33","doi-asserted-by":"publisher","first-page":"11137","DOI":"10.1007\/s13277-014-2412-0","volume":"35","author":"G Zhang","year":"2014","unstructured":"Zhang, G., Liu, Z., Cui, G., Wang, X. & Yang, Z. MicroRNA-486-5p targeting PIM-1 suppresses cell proliferation in breast cancer cells. Tumour Biol. 35, 11137\u201311145. https:\/\/doi.org\/10.1007\/s13277-014-2412-0 (2014).","journal-title":"Tumour Biol."},{"key":"94154_CR34","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/PAI.0000000000000117","volume":"23","author":"M Feinmesser","year":"2015","unstructured":"Feinmesser, M. et al. Specific microRNAs differentiate adrenocortical adenomas from carcinomas and correlate with weiss histopathologic system. Appl Immunohistochem Mol Morphol 23, 522\u2013531. https:\/\/doi.org\/10.1097\/PAI.0000000000000117 (2015).","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"94154_CR35","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1016\/j.bbcan.2012.03.001","volume":"32\u201343","author":"J Zhang","year":"1826","unstructured":"Zhang, J., Zhao, H., Gao, Y. & Zhang, W. Secretory miRNAs as novel cancer biomarkers. Biochim Biophys Acta 32\u201343, 2012. https:\/\/doi.org\/10.1016\/j.bbcan.2012.03.001 (1826).","journal-title":"Biochim Biophys Acta"},{"key":"94154_CR36","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1210\/jc.2018-00817","volume":"103","author":"A Decmann","year":"2018","unstructured":"Decmann, A. et al. MicroRNA expression profiling in adrenal myelolipoma. J Clin Endocrinol Metab 103, 3522\u20133530. https:\/\/doi.org\/10.1210\/jc.2018-00817 (2018).","journal-title":"J Clin Endocrinol Metab"},{"key":"94154_CR37","doi-asserted-by":"publisher","unstructured":"Gatta-Cherifi, B. et al. Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d'etude des Tumeurs Endocrines database. Eur. J. Endocrinol. 166, 269\u2013279. https:\/\/doi.org\/10.1530\/EJE-11-0679 (2012).","DOI":"10.1530\/EJE-11-0679"},{"key":"94154_CR38","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/jid.2014.479","volume":"135","author":"E Penna","year":"2015","unstructured":"Penna, E., Orso, F. & Taverna, D. miR-214 as a key hub that controls cancer networks: small player, multiple functions. J. Invest Dermatol. 135, 960\u2013969. https:\/\/doi.org\/10.1038\/jid.2014.479 (2015).","journal-title":"J. Invest Dermatol."},{"key":"94154_CR39","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1158\/0008-5472.CAN-10-3221","volume":"71","author":"Y Wang","year":"2011","unstructured":"Wang, Y. et al. The tumor suppressor protein menin inhibits AKT activation by regulating its cellular localization. Cancer Res. 71, 371\u2013382. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-3221 (2011).","journal-title":"Cancer Res."},{"key":"94154_CR40","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1158\/1078-0432.CCR-10-3152","volume":"17","author":"HK Oh","year":"2011","unstructured":"Oh, H. K. et al. Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer. Clin. Cancer Res. 17, 2657\u20132667. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-3152 (2011).","journal-title":"Clin. Cancer Res."},{"key":"94154_CR41","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1158\/0008-5472.CAN-11-4112","volume":"72","author":"N Zaidi","year":"2012","unstructured":"Zaidi, N., Swinnen, J. V. & Smans, K. ATP-citrate lyase: a key player in cancer metabolism. Cancer Res. 72, 3709\u20133714. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-4112 (2012).","journal-title":"Cancer Res."},{"key":"94154_CR42","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.3892\/ol.2017.7598","volume":"15","author":"S Tian","year":"2018","unstructured":"Tian, S., Li, P., Sheng, S. & Jin, X. Upregulation of pyruvate kinase M2 expression by fatty acid synthase contributes to gemcitabine resistance in pancreatic cancer. Oncol. Lett. 15, 2211\u20132217. https:\/\/doi.org\/10.3892\/ol.2017.7598 (2018).","journal-title":"Oncol. Lett."},{"key":"94154_CR43","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12944-019-1058-8","volume":"18","author":"L Chang","year":"2019","unstructured":"Chang, L. et al. Inhibition of FASN suppresses the malignant biological behavior of non-small cell lung cancer cells via deregulating glucose metabolism and AKT\/ERK pathway. Lipids Health Dis. 18, 118. https:\/\/doi.org\/10.1186\/s12944-019-1058-8 (2019).","journal-title":"Lipids Health Dis."},{"key":"94154_CR44","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s11745-004-1329-9","volume":"39","author":"SS Chirala","year":"2004","unstructured":"Chirala, S. S. & Wakil, S. J. Structure and function of animal fatty acid synthase. Lipids 39, 1045\u20131053. https:\/\/doi.org\/10.1007\/s11745-004-1329-9 (2004).","journal-title":"Lipids"},{"key":"94154_CR45","first-page":"213","volume":"60","author":"ES Pizer","year":"2000","unstructured":"Pizer, E. S. et al. Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts. Cancer Res 60, 213\u2013218 (2000).","journal-title":"Cancer Res"},{"key":"94154_CR46","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.humpath.2005.11.022","volume":"37","author":"US Shah","year":"2006","unstructured":"Shah, U. S. et al. Fatty acid synthase gene overexpression and copy number gain in prostate adenocarcinoma. Hum. Pathol. 37, 401\u2013409. https:\/\/doi.org\/10.1016\/j.humpath.2005.11.022 (2006).","journal-title":"Hum. Pathol."},{"key":"94154_CR47","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/labinvest.2010.157","volume":"91","author":"KG Zecchin","year":"2011","unstructured":"Zecchin, K. G. et al. Inhibition of fatty acid synthase in melanoma cells activates the intrinsic pathway of apoptosis. Lab Invest. 91, 232\u2013240. https:\/\/doi.org\/10.1038\/labinvest.2010.157 (2011).","journal-title":"Lab Invest."},{"key":"94154_CR48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1073\/pnas.011404098","volume":"98","author":"C Li","year":"2001","unstructured":"Li, C. & Wong, W. H. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc. Natl. Acad. Sci. U S A 98, 31\u201336. https:\/\/doi.org\/10.1073\/pnas.011404098 (2001).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"94154_CR49","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47. https:\/\/doi.org\/10.1093\/nar\/gkv007 (2015).","journal-title":"Nucleic Acids Res."},{"key":"94154_CR50","doi-asserted-by":"publisher","unstructured":"Smyth, G. K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3, Article3, doi:https:\/\/doi.org\/10.2202\/1544-6115.1027 (2004).","DOI":"10.2202\/1544-6115.1027"},{"key":"94154_CR51","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 57, 289\u2013300 (1995).","journal-title":"J R Stat Soc B"},{"key":"94154_CR52","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262 (2001).","journal-title":"Methods"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94154-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94154-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94154-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T15:53:25Z","timestamp":1725465205000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94154-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,20]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["94154"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-94154-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2021,7,20]]},"assertion":[{"value":"3 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14772"}}